Integration of multiple omics reveals key targets and cellular mechanisms for intervention in sarcopenia
Authors:
- 6 December 2025
- journal article
- Published by Elsevier in Archives of Gerontology and Geriatrics
- Vol. 142, 106113
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82070789)
- National Natural Science Foundation of China (82100790)
- Shanghai Jiao Tong University (2022LHB01)
This publication has 62 references indexed in Scilit:
- The Impact of SGLT1 Inhibition on Frailty and Sarcopenia: A Mediation Mendelian Randomization StudyJournal of Cachexia, Sarcopenia and Muscle, 2024
- Adipocyte secreted NRG4 ameliorates age-associated metabolic dysfunctionBiochemical Pharmacology, 2024
- Transcriptome-wide association study of the plasma proteome reveals cis and trans regulatory mechanisms underlying complex traitsThe American Journal of Human Genetics, 2024
- Sarcopenia and mild cognitive impairment among elderly adults: The first longitudinal evidence from CHARLSJournal of Cachexia, Sarcopenia and Muscle, 2022
- Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysisJournal of Cachexia, Sarcopenia and Muscle, 2021
- Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian RandomizationJAMA, 2021
- Mendelian randomisation for mediation analysis: current methods and challenges for implementationEuropean Journal of Epidemiology, 2021
- Association of sarcopenia with mortality and end‐stage renal disease in those with chronic kidney disease: a UK Biobank studyJournal of Cachexia, Sarcopenia and Muscle, 2021
- Malnutrition and sarcopeniaAging Clinical and Experimental Research, 2019
- Sarcopenia: an overviewAging Clinical and Experimental Research, 2017